
JNCI
@JNCI_Now
Followers
25K
Following
2K
Media
3K
Statuses
12K
Publishing impactful cancer research with a global mission, the JNCI family of journals champion quality, innovation, and equity.
Joined April 2009
📢 Calling Early Career Investigators!. Is publishing your research with a respected journal on your 2024 #Resolutions list? . You're in luck - @JNCI_Now is creating a special section devoted to publishing manuscripts from ECIs. Find out more here:
6
8
18
Using a novel, hierarchical approach to ask questions about reasons for a mammogram, article authors showed self-reported reasons for mammography had good agreement with electronic health record data. @kpwaresearch
0
1
1
This systematic review and meta-analysis found that radiation, chemotherapy, and their combination were associated with an increased risk of secondary malignancies after treatment of testicular germ cell tumors, while surgery alone was not. @moosemousa
0
1
4
DFCI, MDACC, SGK, IBC Research Foundation + the Milburn Foundation validate a new IBC web tool that helps providers accurately diagnose inflammatory breast cancer so patients don't miss out on rapid, guideline concordant care. @ibcradiation @mdandersonnews
0
0
0
Asian American, Pacific Islander and White solid organ transplant recipients have higher risk of multiple cancers compared w/ their race-matched general population. Risk difference could vary due to transplantation or other factors. @theNCI @TaoJunRose
0
1
1
Exercise training, especially combined RT + AT, can potentially reduce pro-inflammatory biomarkers in survivors of breast cancer. Considering association between inflammation and tumor progression, exercise should be routinely integrated. @Fbettariga
0
2
4
A @PennCancer team has defined a network of tumor-intrinsic and immune-related molecular traits that distinguish the subset of early stage HPV+ oropharyngeal cancers predisposed to fail standard therapy:. @basulab1 @PennMedicine @Penn_ENT @Penn_CBIO.
0
2
11
Recent clinical trial results in TNBC lacked strong evidence to support using pCR as a surrogate marker for LT survival in early-stage TNBC patients at trial level. LT efficacy+safety of minimising drug approval delay must be assessed.@TYoshiMD @TFujii_MD
0
0
1
Dynamic weight measurements in medical records of patients with advanced cancer enable early identification of those who go on to experience progressive weight loss and shorter survival. @KPCancerRsrch
0
0
0
LLMs show promise in supporting patient-friendly clinical trial educational materials, but human oversight is still needed @dbittermanmd.
0
0
0